(C) Daily Kos
This story was originally published by Daily Kos and is unaltered.
. . . . . . . . . .



Take the time to drop a comment to the FDA [1]

['This Content Is Not Subject To Review Daily Kos Staff Prior To Publication.']

Date: 2025-05-15

The deadline to have your comments considered by the committee was May 14th.

But you can still comment by May 23rd to be heard by the FDA.

Consider a few moments of your time spent could save the life of a high risk individual.



Ask FDA’s Vaccines and Biological Products Committee to ensure universal and twice-a-year access to the COVID vaccine by 12 PM on May 14th

**The FDA VRBPAC, between now and May 14, is accepting comments for the upcoming vaccine committee meeting. Everyone should have access to COVID vaccines, and that it should be available twice a year.**

**Make your voice heard and ask the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) Meeting to:**

* Ensure an updated COVID vaccine by the Fall of 2025

* Recommend updated COVID vaccines for **all ages**

* Strengthen our vaccine drive by recommending **more frequent boosting (at least every six months**) and **more frequent updates to the vaccines**

* Ensure vaccine manufacturers anticipate future dominant strains of SARS-CoV-2.

www.regulations.gov/…

(). Feel free to use our sample language below.

You can also register to give Oral Public Comment at the upcoming May 22, 2025 FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) Meeting at:[ ](https://www2.cdc.gov/vaccines/acip/acip_publiccomment.asp)[https://qualtricsxmjqffz4ktl.qualtrics.com/jfe/form/SV\_dnXIVPWod1OPwdU](https://qualtricsxmjqffz4ktl.qualtrics.com/jfe/form/SV_dnXIVPWod1OPwdU) before 12 p.m. Eastern Time on **May 14, 2024.**

Submitted written comments for the meeting must be received by the FDA [via the Federal Register](https://www.federalregister.gov/documents/2025/05/08/2025-08083/vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishment-of-a) **no later than May 14, 2025** at 11:59 pm Eastern Daylight Time for the committee’s consideration and **May 23, 2025** for the FDA’s consideration.

It’s important to submit a personalized comment, which could emphasize the importance of maintaining universal access, alignment with the next most likely dominant viral strain, and how the lack of vaccine access has impacted or would impact you, or how out-of-pocket costs are a barrier to the health of your family or community. Feel free to take inspiration from or borrow the language in our sample public comment below.

**Step-By-Step Submission Instructions:**

**Step 1.** Go to [Regulations.gov](https://www.regulations.gov/commenton/FDA-2025-N-1146-0001) to submit your comment.

**Step 2.** Type your comment under the field, “Comment.”

**Step 3 (optional).** Submit a PDF or Word version of your comment under “Attach Files.”

**Step 4.** Select either “Individual” or “Anonymous” depending on whether you want to share your personal information that will be publicly available on the Federal Register.

**Step 5.** If select “Individual,” provide your first and last name at minimum. If select “Anonymous,” directly submit a comment without sharing your personal information.

**Final Step 6.** Click “Submit Comment.”

**Letter to FDA VRBPAC:**

>

**END of LETTER**

Full instructions for written and oral comment and meeting information can be found at:[ ](https://www.cdc.gov/vaccines/acip/meetings/index.html)[https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-may-22-2025-meeting-announcement](https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-may-22-2025-meeting-announcement)

Information about the FDA Vaccines and Related Biological Products Advisory Committee Meeting at the Federal Register:[ ](https://www.federalregister.gov/documents/2024/01/16/2024-00674/advisory-committee-on-immunization-practices)[https://www.federalregister.gov/documents/2025/05/08/2025-08083/vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishment-of-a](https://www.federalregister.gov/documents/2025/05/08/2025-08083/vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishment-of-a)

Vaccination with the latest updated vaccines remains one of the most important parts of the multilayered approach to protection against acute illness from COVID infection or developing Long COVID. Far too few Americans have received the latest vaccines. Only approximately [1 in 5 adults and 1 in 10 children have received the latest 2024-2025 vaccines](https://www.cdc.gov/covidvaxview/weekly-dashboard/index.html) (as of April 26, 2025), which have been available since fall 2024.

This spring, receiving an updated fall 2025 will be invaluable for an upcoming wave of infections in the Winter of 2026, especially as vaccine efficacy [wanes significantly four to six months following vaccination](https://www.fda.gov/media/169536/download). Per the CDC’s recommendations, only [immunocompromised ](https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/specific-groups.html)adults are eligible for COVID vaccines more frequently than once a year. Establishing any eligibility criteria is restrictive, putting all of us at risk and leaving those at [high risk of severe consequences of COVID infection](https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html) confused about whether they qualify to receive additional doses. A more frequent vaccination approach and frequent updates to match current variants are needed to better protect all of us amid [year-round COVID spread](https://www.cdc.gov/nwss/rv/COVID19-nationaltrend.html).

With the demise of the [CDC’s Bridge Access Program](https://archive.cdc.gov/#/details?url=https://www.cdc.gov/vaccines/programs/bridge/index.html), which provided COVID vaccines to uninsured and underinsured adults free of charge through the end of December 31, 2024, access is now severely limited. It is important to let public health officials know that cost and any restrictions are barriers to access that are detrimental to health across all populations.

Submitted written comments or registration to make oral comment at the meeting must be received by the CDC **no later than May 23, 2025 at 11:59 pm Eastern Standard Time. If submitted by May 14, 2025, 12 pm, comments will be received in time for the committee’s consideration.**

[END]
---
[1] Url: https://www.dailykos.com/stories/2025/5/15/2322551/-Take-the-time-to-drop-a-comment-to-the-FDA?pm_campaign=front_page&pm_source=more_community&pm_medium=web

Published and (C) by Daily Kos
Content appears here under this condition or license: Site content may be used for any purpose without permission unless otherwise specified.

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/dailykos/

You are viewing proxied material from magical.fish. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.